First 3 runs free, then $50/run
    First 3 runs free, then $50/run

    Investment case

    ARK Innovation ETF

    ARKK · 12 developments mapped · last assessed 2026-09-25

    Market Ontology has mapped 12 macro, policy, and market developments to ARK Innovation ETF since 2026-08-23. Each one is traced from the driver to the valuation assumption it moves, and the valuation below is run on the same engine the subscription uses.

    Last close
    Unavailable
    No published quote
    Market cap
    Unavailable
    Equity value
    Diluted shares
    Unavailable
    Latest reported
    Sector
    Unavailable
    Listing
    Unavailable
    Filings
    Unavailable
    No published filing

    Valuation

    No validated run has been published for ARKK yet, so no modelled value is shown. The ARKK valuation is in the public catch-up queue.

    Subscribers do not wait for the weekly cycle: they run ARKK on demand, against live prices and the latest filings, and change any assumption the developments below move.

    Filed financials

    A validated filed-statement snapshot has not been published for ARKK. Missing data is not estimated or replaced with scenario assumptions.

    Current case

    • Strongest support

      Nvidia in focus after Ark buy and tech-led Q3 earnings upside

      Direct portfolio exposure to NVDA and potential for increased inflows due to successful high-conviction trades.

      · Moves underlying asset performance, fund inflows/outflows

    • Main threat

      10-Year Treasury Yield Surges to 5.041%, Highest Level Since July 2007

      Disproportionate negative impact on growth stocks due to higher discount rates on distant future earnings and increased cost of capital for often unprofitable companies.

      · Moves discount rate for future cash flows, perception of risk for long duration assets

    • Open question

      XFLH Capital Corporation signs letter of intent for business combination with Renogen Biolab Inc.

      Indirect exposure to the biotech sector and growth-oriented companies. A successful de-SPAC in biotech could signal broader sector interest, potentially influencing holdings or future investments.

      · Moves sector sentiment for innovative biotech companies, flows into growth oriented etfs

    What changed, by assumption

    Discount rate for future cash flows
    • 2026-09-1610-Year Treasury Yield Surges to 5.041%, Highest Level Since July 2007
    Underlying asset performance
    • 2026-09-07Tesla shares decline 5.9% following Cybercab debut and federal safety audit
    • 2026-09-07Tesla Shares Drop 5.9% Following Cybercab Event and Federal Safety Audit
    • 2026-09-24Nvidia in focus after Ark buy and tech-led Q3 earnings upside
    • 2026-09-07Tesla Drops 5.9% Following Cybercab Debut and Opening of Federal Safety Audit
    Discount rates for growth stocks
    • 2026-08-23JPMorgan CEO Warns of Record Margin Debt and Systemic Risk
    • 2026-09-09Bitcoin Slips to $78,475 as Fed Rate Hike Odds Cross 60%
    Overall market sentiment for growth stocks
    • 2026-09-10Rocket Lab grows Q2 revenue 62% to $234.1M with record launch backlog
    Growth stock sentiment
    • 2026-09-25ADARx Pharmaceuticals Prices Upsized $446.3M Initial Public Offering at $17

    Event impact log

    Full ledger →
    DateMechanismDirectionHorizonImpact
    2026-09-25ADARx Pharmaceuticals Prices Upsized $446.3M Initial Public Offering at $17Bullish1-5d0.50
    2026-09-24Nvidia in focus after Ark buy and tech-led Q3 earnings upsideBullish1-5d0.60
    2026-09-22XFLH Capital Corporation signs letter of intent for business combination with Renogen Biolab Inc.watch3-12m0.20
    2026-09-18Electra Therapeutics, Inc. IPO — $350Mwatch1-3m0.20
    2026-09-1610-Year Treasury Yield Surges to 5.041%, Highest Level Since July 2007Bearish1-3m0.85
    2026-09-10Rocket Lab grows Q2 revenue 62% to $234.1M with record launch backlogBearish1-3m0.60
    2026-09-09Bitcoin Slips to $78,475 as Fed Rate Hike Odds Cross 60%Bearish1-3m0.60
    2026-09-09Bitcoin Pulls Back to $78,475 as Market Implied Fed Rate Hike Probability Tops 60%Bearish1-3m0.50
    2026-09-07Tesla shares decline 5.9% following Cybercab debut and federal safety auditBearishintraday0.70
    2026-09-07Tesla Shares Drop 5.9% Following Cybercab Event and Federal Safety AuditBearish1-3m0.70
    2026-09-07Tesla Drops 5.9% Following Cybercab Debut and Opening of Federal Safety AuditBearish1-3m0.60
    2026-08-23JPMorgan CEO Warns of Record Margin Debt and Systemic RiskBearish1-3m0.70